Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 2
2002 1
2003 2
2004 1
2005 1
2008 1
2009 2
2010 3
2011 4
2012 3
2013 1
2014 2
2015 1
2017 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study.
Peethambaram PP, Hoskin TL, Day CN, Goetz MP, Habermann EB, Boughey JC. Peethambaram PP, et al. NPJ Breast Cancer. 2017 Oct 19;3:41. doi: 10.1038/s41523-017-0044-4. eCollection 2017. NPJ Breast Cancer. 2017. PMID: 29067357 Free PMC article.
Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, Keeney GL, Cliby WA, Podratz KC. AlHilli MM, et al. Among authors: Peethambaram PP. Gynecol Oncol. 2014 Jun;133(3):485-93. doi: 10.1016/j.ygyno.2014.03.567. Epub 2014 Mar 29. Gynecol Oncol. 2014. PMID: 24690476 Free PMC article.
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.
Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, Gnanaolivu R, Lee KY, Lindstrom T, Armasu S, Fitz-Gibbon P, Ghosh K, Stan DL, Pruthi S, Neal L, Sandhu N, Rhodes DJ, Klassen C, Peethambaram PP, Haddad TC, Olson JE, Hoskin TL, Goetz MP, Domchek SM, Boughey JC, Ruddy KJ, Couch FJ. Yadav S, et al. Among authors: Peethambaram PP. J Clin Oncol. 2020 Mar 3:JCO1902190. doi: 10.1200/JCO.19.02190. Online ahead of print. J Clin Oncol. 2020. PMID: 32125938
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors.
Peethambaram PP, Hartmann LC, Jonker DJ, de Jonge M, Plummer ER, Martin L, Konner J, Marshall J, Goss GD, Teslenko V, Clemens PL, Cohen LJ, Ahlers CM, Alland L. Peethambaram PP, et al. Invest New Drugs. 2015 Apr;33(2):321-31. doi: 10.1007/s10637-014-0171-9. Epub 2014 Nov 8. Invest New Drugs. 2015. PMID: 25380635 Clinical Trial.
Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.
Kasi PM, Patnaik MM, Peethambaram PP. Kasi PM, et al. Among authors: Peethambaram PP. Case Rep Hematol. 2013;2013:146938. doi: 10.1155/2013/146938. Epub 2013 Dec 11. Case Rep Hematol. 2013. PMID: 24396616 Free PMC article.
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma.
Hendrickson AE, Oberg AL, Glaser G, Camoriano JK, Peethambaram PP, Colon-Otero G, Erlichman C, Ivy SP, Kaufmann SH, Karnitz LM, Haluska P. Hendrickson AE, et al. Among authors: Peethambaram PP. Gynecol Oncol. 2012 Feb;124(2):210-5. doi: 10.1016/j.ygyno.2011.10.002. Epub 2011 Nov 1. Gynecol Oncol. 2012. PMID: 22047770 Free PMC article. Clinical Trial.
Inherited determinants of ovarian cancer survival.
Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, Vierkant RA, Armasu SM, White KL, Keeney GL, Cliby WA, Rider DN, Kelemen LE, Jones MB, Peethambaram PP, Lancaster JM, Olson JE, Schildkraut JM, Cunningham JM, Hartmann LC. Goode EL, et al. Among authors: Peethambaram PP. Clin Cancer Res. 2010 Feb 1;16(3):995-1007. doi: 10.1158/1078-0432.CCR-09-2553. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103664 Free PMC article.
Second-line and subsequent therapy for ovarian carcinoma.
Peethambaram PP, Long HJ. Peethambaram PP, et al. Curr Oncol Rep. 2002 Mar;4(2):159-64. doi: 10.1007/s11912-002-0077-0. Curr Oncol Rep. 2002. PMID: 11822988 Review.
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.
Bible KC, Peethambaram PP, Oberg AL, Maples W, Groteluschen DL, Boente M, Burton JK, Gomez Dahl LC, Tibodeau JD, Isham CR, Maguire JL, Shridhar V, Kukla AK, Voll KJ, Mauer MJ, Colevas AD, Wright J, Doyle LA, Erlichman C; Mayo Phase 2 Consortium (P2C); North Central Cancer Treatment Group (NCCTG). Bible KC, et al. Among authors: Peethambaram PP. Gynecol Oncol. 2012 Oct;127(1):55-62. doi: 10.1016/j.ygyno.2012.05.030. Epub 2012 Jun 1. Gynecol Oncol. 2012. PMID: 22664059 Free PMC article. Clinical Trial.
24 results
Jump to page
Feedback